Paul R. Harnett
The University of Sydney(AU)Westmead Hospital(AU)Sydney Local Health District(AU)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Cancer Genomics and Diagnostics, CRISPR and Genetic Engineering, RNA modifications and cancer
Most-Cited Works
- → Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial(2017)1,678 cited
- → Whole–genome characterization of chemoresistant ovarian cancer(2015)1,618 cited
- → Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer(2017)391 cited
- → Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas(2009)301 cited
- → ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer(2014)227 cited
- → Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression.(1989)219 cited